Selected References

Virology

Head of Institute:
Prof. Dr. med. Klaus Überla

Selected References

  • Reichel, A., Stilp, A.C., Scherer, M., Reuter, N., Lukassen, S., Ksmapour, B., Schreiner, S., Cicin-Sain, L., Winterpacht, A., Stamminger, T. (2018). Chromatin-remodeling factor SPOC1 acts as a cellular restriction factor against human cytomegalovirus by repressing the major immediate early promoter. J Virol. 92(14), pii: e00342-18.
  • Cloarec, R., Bauer, S., Teissier, N., Schaller, F., Luche, H., Courtens, S., Salmi, M., Pauly, V., Bois, E., Pallesi-Pocachard, E., Buhler, E., Michel, F.J., Gressens, P., Malissen, M., Stamminger, T., Streblow, D.N., Bruneau, N., Szepetowski, P. (2018). In Utero Administration of Drugs Targeting Microglia Improves the Neurodevelopmental Outcome Following Cytomegalovirus Infection of the Rat Fetal Brain. Front Cell Neurosci. 12: 55, doi: 10.3389/fncel.2018.00055.
  • Reuter, N., Reichel, A., Stilp, A.C., Scherer, M., Stamminger, T. (2018). SUMOylation of IE2p86 is required for efficient autorepression of the human cytomegalovirus major immediate-early promoter. J Gen Virol., doi: 10.1099/ jgv.0.001021.
  • Wu, Z., Qin, R., Wang, L., Bosso, M., Scherer, M., Stamminger, T., Hotter, D., Mertens, T., Frascaroli, G. (2017). Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses. J Virol. 91(22), pii: e00678-17. doi: 10.1128/JVI.00678-17.
  • Reuter, N., Schilling, E.M., Scherer, M., Müller, R., Stamminger, T. (2017). The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus. J Virol. 91(10), pii: e02335-16. doi: 10.1128/JVI.02335-16.
  • Heilingloh, C.S., Grosche, L., Kummer, M., Mühl-Zürbes, P., Kamm, L., Scherer, M., Latzko, M., Stamminger, T., Steinkasserer, A. (2017). The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells. Front Microbiol. 8: 119, doi: 10.3389/fmicb.2017.00119.
  • Schilling, E.M., Scherer, M., Reuter, N., Schweininger, J., Muller, Y.A., Stamminger, T. (2017). The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation. J Virol. 91(4), pii: e02049-16, doi: 10.1128/JVI.02049-16.
  • Frank, T., Reichel, A., Larsen, O., Stilp, A.C., Rosenkilde, M.M., Stamminger, T., Ozawa, T., Tschammer, N. (2016). Attenuation of chemokine receptor function and surface expression as an immunomodulatory strategy employed by human cytomegalovirus is linked to vGPCR US28. Cell Commun Signal. 14(1): 31.
  • Lamm, C.E., Scherer, M., Reuter, N., Amin, B., Stamminger, T., Sonnewald, U. (2016). Human promyelocytic leukemia protein is targeted to distinct subnuclear domains in plant nuclei and colocalizes with nucleolar constitutents in a SUMO-dependent manner. FEBS Open Bio. 6(11): 1141-1154, doi: 10.1002/2211-5463.12134.
  • Kim, Y.J., Kim, E.T., Lee, M.K., Kwon, K.M., Kim, K.I., Stamminger, T., Ahn, J.H. (2016). Consecutive inhibition of ISG15 expression and ISGylation by cytomegalovirus regulators. PLoS Pathog. 12(8): e1005850.
  • Zheng, Y., Stamminger, T., Hearing, P. (2016). E2F/Rb family of proteins mediate interferon induced repression of adenovirus immediate early transcription to promote persistent viral replication. PLoS Pathog. 12(1): e1005415.